Top Suppliers:I want be here

80937-31-1

80937-31-1 structure
80937-31-1 structure
  • Name: Flosulide
  • Chemical Name: N-[6-(2,4-difluorophenoxy)-1-oxo-2,3-dihydroinden-5-yl]methanesulfonamide
  • CAS Number: 80937-31-1
  • Molecular Formula: C16H13F2NO4S
  • Molecular Weight: 353.34100
  • Catalog: Research Areas Inflammation/Immunology
  • Create Date: 2018-05-16 08:00:00
  • Modify Date: 2024-01-11 21:59:54
  • Flosulide is a potent and selective COX-2 inhibitor, used for the treatment for inflammatory diseases.

Name N-[6-(2,4-difluorophenoxy)-1-oxo-2,3-dihydroinden-5-yl]methanesulfonamide
Synonyms n-[6-(2,4-difluorophenoxy)-1-oxo-2,3-dihydro-1h-inden-5-yl]methanesulfonamide
N-[6-(2,4-difluorophenoxy)-2,3-dihydro-1-oxo-1H-inden-5-yl]methanesulfonamide
6-(2,4-difluorophenoxy)-5-methylsulfonylamino-1-indanone
5-methanesulfonamido-6-((2,4-difluorophenyl)oxy)-1-indanone
Flosulida [INN-Spanish]
Flosulidum
N-[6-(2,4-Difluoro-phenoxy)-1-oxo-indan-5-yl]-methanesulfonamide
Flosulidum [INN-Latin]
N-(6-(2,4-Difluorophenoxy)-1-oxo-5-indanyl)methanesulfonamide
Flosulide
Flosulida
Description Flosulide is a potent and selective COX-2 inhibitor, used for the treatment for inflammatory diseases.
Related Catalog
Target

COX-2

In Vitro Flosulide (1 nM-100 μM) causes a concentration-dependent and finally complete inhibition of PGE2 production in the OSC-2 cell line, but with no effect on PG formation in the OSC-1 cells. Flosulide completely suppresses mitotic activity of OSC-2 cells, whereas mitotic activity of OSC-1 cells remain unchanged[2].
In Vivo In normovolemic rats, flosulide increases renal plasma flow (RPF) and and glomerular filtration rate (GFR). In hypovolemic rats, flosulide (5-25 mg/kg) reduces RPF and GFR. Flosulide at 5 mg/kg reduces 6-keto-PGF1alpha whereas at 25 mg/kg and after indomethacin at 10 mg/kg a fall in 6-keto-PGF1alpha and TXB2 appeares[1]. Flosulide (0.75 mg/day) significantly reduces proteinuria as compared to aspirin treatment. Plasma protein and albumin levels are significantly lower in the aspirin-treated group than in flosulide-treated rats[3].
Cell Assay The proliferation of the esophageal tumor cell lines is determined using the cell proliferation kit II. Tumor cells are incubated with flosulide and NS-398 at different concentrations for 48 h in DMEM containing FCS (10%), penicillin (100 units/mL), and streptomycin (0.1 mg/mL). After this time, the XTT labeling mixture is added, followed by 4 h of incubation and measurement of absorbance at 490 nm.
References

[1]. Turull A, et al. Acute effects of the anti-inflammatory cyclooxygenase-2 selective inhibitor, flosulide, on renal plasma flow and glomerular filtration rate in rats. Inflammation. 2001 Apr;25(2):119-28.

[2]. Zimmermann KC, et al. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res. 1999 Jan 1;59(1):198-204.

[3]. Heise G, et al. Different actions of the cyclooxygenase 2 selective inhibitor flosulide in rats with passive Heymann nephritis. Nephron. 1998 Oct;80(2):220-6.

Density 1.506g/cm3
Boiling Point 446.9ºC at 760 mmHg
Molecular Formula C16H13F2NO4S
Molecular Weight 353.34100
Flash Point 224.1ºC
Exact Mass 353.05300
PSA 80.85000
LogP 4.41130
Index of Refraction 1.62
Storage condition 2-8℃